A team of researchers from Drexel University has proposed a way to detect Lyme disease by looking for a unique polymer-protein indicator that occurs before the immune reaction is triggered. The group’s method recently received a boost from a U.S. Department of Health and Human Services and the Steve & Alexandra Cohen Foundation initiative to finally find an effective test for the disease.
/PRNewswire/ GlycoPath s proprietary GlycoTyper™ immunoaffinity technology was used to distinguish between Lyme disease infection states and track treatment.